Adherence to therapy and spacer use during lockdown
| Variables | n (% (95% CI)) |
| Asthma controller use | |
| No | 56 (19 (14.4 to 23.3)) |
| Yes | 241 (81 (76.2 to 85.4)) |
| Fluticasone inhaler | 126 (52 (45.8 to 58.7)) |
| Fluticasone/salmeterol | 65 (27 (21.5 to 33.5)) |
| Beclomethasone inhaler | 39 (16 (11.8 to 21.5)) |
| Nebulised beclomethazone | 11 (5 (2.3 to 8.0)) |
| Use of inhaler with a spacer | |
| No | 102 (34 (29 to 40)) |
| Yes | 195 (66 (60 to 71)) |
| Daily | 117 (60 (52.8 to 67.0)) |
| Most of the time (4–6 days/week) | 29 (15 (10.2 to 20.7)) |
| Rarely (<3 days/weeks) | 49 (25 (19.2 to 31.8)) |
| Reasons for no compliance on controller | |
| Fear of dependency | 42 (41 (31.5 to 51.4)) |
| Forgetfulness | 20 (20 (12.4 to 28.7)) |
| Fear of side effects | 40 (39 (29.7 to 49.4)) |
| COVID-19 pandemic has increased adherence to medications | |
| Yes | 181 (61 (55.1 to 66.5)) |
| No | 116 (39 (33.5 to 44.9)) |
| Did child continue using preventers on prescribed dose during lockdown? | |
| Yes | 194 (65 (59.6 to 70.7)) |
| No | 103 (35 (29.3 to 40.4)) |
| Reasons for no using/reducing dose of medications | |
| Child was stable during lockdown. | 81 (79 (69.5 to 86.1) |
| Complicated procedure to get medicine for hospital | 16 (16 (9.2 to 24.0)) |
| Inability to reach hospital during lockdown | 6 (6 (2.2 to 12.3)) |
| Days of SABA* use per week during the lockdown | |
| Less than 2 days | 227 (76 (71.2 to 81.1)) |
| 2–4 days | 47 (16 (11.9 to 20.5)) |
| 5 or more | 23 (8 (5.0 to 11.4)) |